Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
296.9 USD | -0.55% | -2.62% | +3.13% |
12:30pm | RBC Raises Price Target on Amgen to $332 From $328, Maintains Outperform Rating | MT |
Jun. 13 | Race Oncology Validates Efficacy of Blood Cancer Therapy in Animal Study; Shares Rise 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.64% | 160B | |
+51.54% | 795B | |
+42.16% | 627B | |
-7.20% | 350B | |
+18.67% | 328B | |
+7.48% | 294B | |
+17.91% | 245B | |
+1.39% | 222B | |
+12.17% | 215B | |
-3.96% | 157B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Transcript : Amgen Inc. - Special Call